Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension

BACKGROUND/AIMS: Angiotensin receptor blockers (ARBs) inhibit activated hepatic stellate cell contraction and are thought to reduce the dynamic portion of intrahepatic resistance. This study compared the effects of combined treatment using the ARB candesartan and propranolol versus propranolol monot...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clin Mol Hepatol
Hauptverfasser: Kim, Jae Hyun, Kim, Jung Min, Cho, Youn Zoo, Na, Ji Hoon, Kim, Hyun Sik, Kim, Hyoun A, Kang, Hye Won, Baik, Soon Koo, Kwon, Sang Ok, Cha, Seung Hwan, Kim, Young Ju, Kim, Moon Young
Format: Artigo
Sprache:Inglês
Veröffentlicht: The Korean Association for the Study of the Liver 2014
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4278069/
https://ncbi.nlm.nih.gov/pubmed/25548744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2014.20.4.376
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge